Stock listing
69C Stock Price, News, Filings & Events — Tvardi Therapeutics, Inc.
Selected listing: 69C · GETTEX · EUR · DE
This page tracks Tvardi Therapeutics, Inc.'s 69C:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 69C:GETTEX. 69C:GETTEX is the stock-level entry point for investors researching Tvardi Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Tvardi Therapeutics, Inc. (TVRD) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- 69C:GETTEX
- Asset type
- Stock
- Market cap
- $21.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- GETTEX
- Currency
- EUR
Tvardi Therapeutics, Inc. 69C:GETTEX stock context
This page tracks Tvardi Therapeutics, Inc.'s 69C:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 69C:GETTEX. 69C:GETTEX is the stock-level entry point for investors researching Tvardi Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Tvardi Therapeutics, Inc. (TVRD) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Tvardi Therapeutics, Inc.
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update
August 14, 2026
Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026
August 12, 2026
Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109
July 30, 2026
Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement
July 7, 2026
Tvardi Therapeutics to Participate in Upcoming Investor Events
May 21, 2026
Tvardi Therapeutics, Inc. earnings calls
Cara Therapeutics, Inc. (CARA) Q4 2023 Earnings Call
March 4, 2024 · Replay with transcript and chapters
Cara Therapeutics, Inc. (CARA) Q3 2023 Earnings Call
November 13, 2023 · Replay with transcript and chapters
Cara Therapeutics, Inc. (CARA) Q2 2023 Earnings Call
August 7, 2023 · Replay with transcript and chapters
Cara Therapeutics, Inc. (CARA) Q1 2023 Earnings Call
May 15, 2023 · Replay with transcript and chapters
Cara Therapeutics, Inc. (CARA) Q4 2022 Earnings Call
March 6, 2023 · Replay with transcript and chapters
Cara Therapeutics, Inc. (CARA) Q3 2022 Earnings Call
November 7, 2022 · Replay with transcript and chapters
Research Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for 69C:GETTEX.
Tvardi Therapeutics, Inc. company profile
View the public company page for Tvardi Therapeutics, Inc. on 6ix.
Tvardi Therapeutics, Inc. news
Read company news and market updates connected to Tvardi Therapeutics, Inc..
Tvardi Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Tvardi Therapeutics, Inc..
Alternate listings
TVRD:NASDAQ
US · USD
Alternate listing for Tvardi Therapeutics, Inc.; the primary context on this page is 69C:GETTEX.
A414VY:LS
DE · EUR
Alternate listing for Tvardi Therapeutics, Inc.; the primary context on this page is 69C:GETTEX.
A414VY:LSX
DE · EUR
Alternate listing for Tvardi Therapeutics, Inc.; the primary context on this page is 69C:GETTEX.
69C:FWB
DE · EUR
Alternate listing for Tvardi Therapeutics, Inc.; the primary context on this page is 69C:GETTEX.
69C:TRADEGATE
DE · EUR
Alternate listing for Tvardi Therapeutics, Inc.; the primary context on this page is 69C:GETTEX.
69C0:SWB
DE · EUR
Alternate listing for Tvardi Therapeutics, Inc.; the primary context on this page is 69C:GETTEX.
0HTC:LSE
GB · USD
Alternate listing for Tvardi Therapeutics, Inc.; the primary context on this page is 69C:GETTEX.
TVRD:BOATS
US · USD
Alternate listing for Tvardi Therapeutics, Inc.; the primary context on this page is 69C:GETTEX.
TVRD:BX
CH · CHF
Alternate listing for Tvardi Therapeutics, Inc.; the primary context on this page is 69C:GETTEX.
69C:MUN
DE · EUR
Alternate listing for Tvardi Therapeutics, Inc.; the primary context on this page is 69C:GETTEX.